Pharma Engineering ApS: Financial statements 2022
CVR: 42133590
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Engineering ApS (CVR 42133590) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK 5,683 compared with DKK 2,183 the year before. Equity in the 2022 report amounted to DKK 47,866. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 5,683
- Equity
- DKK 47,866
- Total Assets
- DKK 47,866
- Employees
- 0
Keep an eye on Pharma Engineering ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Engineering ApS has published its interim report for the period February 14, 2021 – December 31, 2021.
About Pharma Engineering ApS
Pharma Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mads Mose Onsberg. The company is owned by Mads Mose Onsberg. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 6,370 compared with DKK 1,475 the year before. Equity in the 2025 report amounted to DKK 51,317.